Harmony Biosciences Holdings, Inc
Price
FilingsNewest: 10-Q, Quarterly reportAug 4 →InsidersNo open-market buys. 2 insiders sold $2.8M, all 6 sales on a 10b5-1 plan.→HoldersBlackRock 12.2%FMR 6.1%Vanguard Portfolio 5.0%→PeersClosest companies: AXSM, PRAX, ATAI→
From the filings
Figures
- Revenue
- $959.9Mlast 12 months
- Net income
- $181.3Mlast 12 months
- Operating cash flow
- $342.0Mlast 12 months
- Cash and equivalents
- $549.8Mat the last balance sheet
- Total debt
- $154.0Mat the last balance sheet
- Shares outstanding
- 58.1M shareson issue